Speakers

 

 

 ​

 

 

 ​​​​


 
 
 
Speakers >
 
About the Speaker
  

 

Dr Melvin CHUA Lee Kiang
 

Head, Department of Head & Neck and Thoracic, National Cancer Centre Singapore (NCCS)


• Speaker, Oncology, and Cancer and Stem Cell Biology Plenary, 17 Sep 2021


 

                                

Dr Melvin Chua is a Clinician-Scientist at the NCCS, and Principal Investigator of the Tan Chin Tuan Laboratory of Optical Imaging, Photodynamic and Proton Beam Therapy – Precision Radiation Oncology Programme, Division of Radiation Oncology. His research is supported by the National Medical Research Council (NMRC) Clinician Scientist award, and is focused on discovery and translational cancer genomics, and the development of biomarker-directed clinical trials in Nasopharyngeal and Prostate Cancers (NPC).


He graduated from the NUS Yong Loo Lin School of Medicine, in 2002. He obtained his Fellowship in Clinical Oncology from the Royal College of Radiologists, and his Doctorate from the University College London in 2013. He later completed post-doctoral Clinician Scientist fellowships at the Mount Vernon Cancer Centre, UK, and the Princess Margaret Cancer Centre, Toronto.


Dr Chua is a KOL on NPC and prostate cancer, and he has been invited to speak at more than 100 international meetings. He is also on the scientific advisory board for the NPC Guangzhou-Singapore Trial Network and a board member on the Head Neck Cancer International Group (HNCIG).


His academic activities include his roles as the Associate Senior Editor of the International Journal of Radiation Oncology Biology Physics – Official journal of the American Society of Radiation Oncology and Editor-in-Chief, Annals of Nasopharynx Cancer. He also serves on the International Education Steering Group and the Asia-Pacific Regional Council of the American Society of Clinical Oncology (ASCO). He has published over 80 peer-reviewed papers, with a H-index of 22, including highly cited articles in the New England Journal of Medicine, Lancet, Nature, Cell, Journal of Clinical Oncology and JAMA Oncology.




                             


 

 

                                  

 

 

 

 
 
 
Disclaimer